Legis Daily

Cosmetic Safety Enhancement Act of 2019

USA116th CongressHR-5279| House 
| Updated: 3/11/2020
Frank Pallone

Frank Pallone

Democratic Representative

New Jersey

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Cosmetic Safety Enhancement Act of 2019 This bill authorizes the Food and Drug Administration (FDA) to take various actions with respect to the regulation of cosmetics, such as collecting fees from manufacturers and distributors to fund cosmetics safety activities. The bill also authorizes the FDA to suspend the distribution of products that have a reasonable probability of causing serious adverse health consequences.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 3, 2019
Introduced in House
Dec 3, 2019
Referred to the House Committee on Energy and Commerce.
Dec 4, 2019
Referred to the Subcommittee on Health.
Mar 11, 2020
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Mar 11, 2020
Subcommittee Consideration and Mark-up Session Held.
  • December 3, 2019
    Introduced in House


  • December 3, 2019
    Referred to the House Committee on Energy and Commerce.


  • December 4, 2019
    Referred to the Subcommittee on Health.


  • March 11, 2020
    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .


  • March 11, 2020
    Subcommittee Consideration and Mark-up Session Held.

Health

Related Bills

  • S 116-726: Personal Care Products Safety Act
Animal protection and human-animal relationshipsBusiness recordsCongressional oversightConsumer affairsCosmetics and personal careDrug safety, medical device, and laboratory regulationGovernment information and archivesInflation and pricesInternet and video servicesInternet, web applications, social mediaLicensing and registrationsManufacturingPerformance measurementProduct safety and qualityUser charges and fees

Cosmetic Safety Enhancement Act of 2019

USA116th CongressHR-5279| House 
| Updated: 3/11/2020
Cosmetic Safety Enhancement Act of 2019 This bill authorizes the Food and Drug Administration (FDA) to take various actions with respect to the regulation of cosmetics, such as collecting fees from manufacturers and distributors to fund cosmetics safety activities. The bill also authorizes the FDA to suspend the distribution of products that have a reasonable probability of causing serious adverse health consequences.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 3, 2019
Introduced in House
Dec 3, 2019
Referred to the House Committee on Energy and Commerce.
Dec 4, 2019
Referred to the Subcommittee on Health.
Mar 11, 2020
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Mar 11, 2020
Subcommittee Consideration and Mark-up Session Held.
  • December 3, 2019
    Introduced in House


  • December 3, 2019
    Referred to the House Committee on Energy and Commerce.


  • December 4, 2019
    Referred to the Subcommittee on Health.


  • March 11, 2020
    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .


  • March 11, 2020
    Subcommittee Consideration and Mark-up Session Held.
Frank Pallone

Frank Pallone

Democratic Representative

New Jersey

Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 116-726: Personal Care Products Safety Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Animal protection and human-animal relationshipsBusiness recordsCongressional oversightConsumer affairsCosmetics and personal careDrug safety, medical device, and laboratory regulationGovernment information and archivesInflation and pricesInternet and video servicesInternet, web applications, social mediaLicensing and registrationsManufacturingPerformance measurementProduct safety and qualityUser charges and fees